correct me if I'm wrong but don't the pharmacies need to just have 10 patients on the app to break even? Pharmacies should also be able to save on labour if they use the app so I would argue $159/month is pretty low
Here's another question: why are they pitching the stock to US investors and who is the audience? It's a bit small and illiquid to attract the big fish
MDR Price at posting:
32.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
